Clinical Trials Browser

Phase 1/2 × Has results × montanide ISA 51 × Clear all

NCT02425306 2023-10-30

Mel63; CHAMP

Phase 1/2 Terminated

48 enrolled 13 charts

Melanoma

NCT00145158 2022-10-10

Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma

Phase 1/2 Terminated

23 enrolled 8 charts

Melanoma